Search | IOVS | ARVO Journals

Showing 1 – 20 of 77

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Classification of Intermediate Age-Related Macular Degeneration by Short-Term Risk for Atrophy on Spectral Domain Optical Coherence Tomography

Eleonora M Lad; Karim Sleiman; David L Banks; Sanjay Hariharan; Traci E Clemons; Emily Y Chew; Cynthia A Toth

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2213. doi:

ARVO Annual Meeting Abstract July 2019

Charles Bonnet Syndrome in Participants of the Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-on

Elvira Agron; Emily Y Chew; Tiarnan D L Keenan; Traci E Clemons

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1173. doi:

ARVO Annual Meeting Abstract July 2019

Genetic factors associated with reticular pseudodrusen in participants of the Age-Related Eye Disease Study 2 (AREDS2)

Christopher Hwang; Elvira Agron; Traci E Clemons; Tiarnan D L Keenan; Catherine A Cukras; Wai T Wong; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1194. doi:

ARVO Annual Meeting Abstract July 2019

Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment

Jessica Loo; Traci E Clemons; Emily Y Chew; Martin Friedlander; Glenn J Jaffe; Sina Farsiu

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1449. doi:

ARVO Annual Meeting Abstract July 2019

Reticular Pseudodrusen as a Risk Factor for Progression of Age-related Macular Degeneration

Amitha Domalpally; Jeong W Pak; Elvira Agron; Traci E Clemons; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2216. doi:

ARVO Annual Meeting Abstract July 2019

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Ferenc B Sallo; Vincent Rocco; Irene Leung; Adam M Dubis; Ute EK Wolf-Schnurrbusch; Catherine A Egan; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5049. doi:

ARVO Annual Meeting Abstract July 2019

Association of short-term progression in AMD score with risk of development of late AMD and vision loss in the AREDS2 study

Susan Vitale; Elvira Agron; Traci E Clemons; Amitha Domalpally; Ronald P Danis; Tiarnan D L Keenan; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):52. doi:

ARVO Annual Meeting Abstract July 2019

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

Emily Y Chew; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Ferenc B Sallo; Tjebo Heeren; Catherine A Egan; Peter Charbel Issa; Konstatinos Balaskas; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1335. doi:

ARVO Annual Meeting Abstract July 2018

Longitudinal Structure/Function Correlation Between Microperimetry and OCT Imaging in Type 2 Macular Telangiectasia (MacTel)

Traci E Clemons; Emily Y. Chew; Eleonora M Lad; Glenn J Jaffe; Sina Farsiu; Sarah Duwel; David Cunefare; Dibyendu Mukherji

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1839. doi:

ARVO Annual Meeting Abstract July 2018

Clinical Course and Outcomes of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration in AREDS2

Jeannette J Yu; Elvira Agron; Catherine A Cukras; Traci E Clemons; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5548. doi:

ARVO Annual Meeting Abstract July 2018

Geographic atrophy of age-related macular degeneration in the Age-Related Eye Disease Study 2 (AREDS2): incidence, clinical characteristics and factors influencing growth rate

Tiarnan D L Keenan; Elvira Agron; Amitha Domalpally; Traci E Clemons; Freekje Van Asten; Wai T Wong; Ronald P Danis; Michael L Klein; Rinki Ratnapriya; Anand Swaroop; Frederick L Ferris; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6010. doi:

ARVO Annual Meeting Abstract July 2018

Visual acuity outcomes in eyes treated with anti-VEGF injections during the Age-Related Eye Disease Study 2 (AREDS2)

Susan Vitale; Elvira Agron; Tiarnan Keenan; Traci E Clemons; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6013. doi:

ARVO Annual Meeting Abstract July 2018

Association of Diet to the Development of Late AMD in Participants of AREDS

Elvira Agron; Emily Y. Chew; Julie A. Mares; Esther MEZHIBOVSKY; Traci E Clemons; Freekje Van Asten

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2381. doi:

ARVO Annual Meeting Abstract July 2018

Fundus autofluorescence risk factors for progression of geographic atrophy (GA) in the Age-Related Eye Disease Study 2

Jeong W Pak; Amitha Domalpally; Elvira Agron; Ronald P Danis; Traci E Clemons; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2422. doi:

ARVO Annual Meeting Abstract July 2018

Comparison of fluorescein angiography lesion size of choroidal neovascularization associated with age-related macular degeneration in participants and non-participants of the home tele-monitoring study (ForeseeHome Study)

Ramiro S Maldonado; Elvira Agron; Traci E Clemons; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2391. doi:

ARVO Annual Meeting Abstract July 2018

Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2

Emily Y. Chew; Traci E Clemons; Glenn J Jaffe; Sina Farsiu; eleonora lad; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2605. doi:

ARVO Annual Meeting Abstract July 2018

Macular photoreceptor atrophy defines the end stage of macular telangiectasia type 2

Tjebo FC Heeren; Traci E Clemons; Marcus Fruttiger; Catherine Egan; Peter Charbel Issa

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3138. doi:

ARVO Annual Meeting Abstract July 2018

Assessing photoreceptor degeneration in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Adam M Dubis; Irene Leung; Traci E Clemons; Daniel Pauleikhoff; Emily Y. Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3139. doi:

Special Issue September 2017

Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2

PDF

Dibyendu Mukherjee; Eleonora M. Lad; Ryan R. Vann; Stephanie J. Jaffe; Traci E. Clemons; Martin Friedlander; Emily Y. Chew; Glenn J. Jaffe; Sina Farsiu; for the MacTel Study Group
TAGS: telangiectasis, diagnostic imaging, eye, optical coherence tomography, personal integrity, spectral-domain optical coherence tomography
Invest. Ophthalmol. Vis. Sci.. 2017; 58(6):BIO291-BIO299. doi: 10.1167/iovs.17-21834

ARVO Annual Meeting Abstract June 2017

Getting to the root of MacTel: joint dissection of genetic risk loci and ocular phenotypes

Roberto Bonelli; Thomas Scerri; Traci E Clemons; Ferenc Sallo; Irene Leung; The MacTel Consortium; Tunde Peto; Melanie Bahlo

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):178. doi:

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Classification of Intermediate Age-Related Macular Degeneration by Short-Term Risk for Atrophy on Spectral Domain Optical Coherence Tomography

Charles Bonnet Syndrome in Participants of the Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-on

Genetic factors associated with reticular pseudodrusen in participants of the Age-Related Eye Disease Study 2 (AREDS2)

Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment

Reticular Pseudodrusen as a Risk Factor for Progression of Age-related Macular Degeneration

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Association of short-term progression in AMD score with risk of development of late AMD and vision loss in the AREDS2 study

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

Longitudinal Structure/Function Correlation Between Microperimetry and OCT Imaging in Type 2 Macular Telangiectasia (MacTel)

Clinical Course and Outcomes of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration in AREDS2

Geographic atrophy of age-related macular degeneration in the Age-Related Eye Disease Study 2 (AREDS2): incidence, clinical characteristics and factors influencing growth rate

Visual acuity outcomes in eyes treated with anti-VEGF injections during the Age-Related Eye Disease Study 2 (AREDS2)

Association of Diet to the Development of Late AMD in Participants of AREDS

Fundus autofluorescence risk factors for progression of geographic atrophy (GA) in the Age-Related Eye Disease Study 2

Comparison of fluorescein angiography lesion size of choroidal neovascularization associated with age-related macular degeneration in participants and non-participants of the home tele-monitoring study (ForeseeHome Study)

Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2

Macular photoreceptor atrophy defines the end stage of macular telangiectasia type 2

Assessing photoreceptor degeneration in type 2 idiopathic macular telangiectasia.

Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2

Getting to the root of MacTel: joint dissection of genetic risk loci and ocular phenotypes

To View More...

You must be signed into an individual account to use this feature.